Average Co-Inventor Count = 4.71
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xerox Corporation (46 from 24,195 patents)
2. Incyte Corporation (12 from 666 patents)
3. Xenon Pharmaceuticals Inc. (1 from 109 patents)
59 patents:
1. 12421197 - Aminopyrazine derivatives as PI3K-γ inhibitors
2. 12173006 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
3. 12030885 - Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors
4. 11926630 - Tertiary alcohols as PI3K-γ inhibitors
5. 11780840 - Tricyclic urea compounds as JAK2 V617F inhibitors
6. 11661422 - Tricyclic urea compounds as JAK2 V617F inhibitors
7. 11225486 - Tertiary alcohols as PI3K-γ inhibitors
8. 11186580 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
9. 11046658 - Aminopyrazine derivatives as PI3K-γ inhibitors
10. 10975088 - Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
11. 10738057 - Tertiary alcohols as PI3K-γ inhibitors
12. 10479795 - Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors
13. 10133204 - Imaging device components comprised of hydrophobic carbon nanotubes
14. 10100060 - Asymmetric synthesis of funapide
15. 9494888 - Imaging device components comprised of hydrophobic carbon nanotubes